Mettler-Toledo International Inc. (NYSE:MTD) Expected to Post Quarterly Sales of $871.48 Million

Equities analysts forecast that Mettler-Toledo International Inc. (NYSE:MTD – Get Rating) will announce $871.48 million in sales for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Mettler-Toledo International’s earnings. The highest sales estimate is $874.73 million and the lowest is $866.90 million. Mettler-Toledo International posted sales of $804.39 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 8.3%. The business is scheduled to announce its next quarterly earnings report after the market closes on Monday, January 1st.

According to Zacks, analysts expect that Mettler-Toledo International will report full-year sales of $3.95 billion for the current fiscal year, with estimates ranging from $3.94 billion to $3.95 billion. For the next financial year, analysts anticipate that the company will post sales of $4.19 billion, with estimates ranging from $4.15 billion to $4.23 billion. Zacks’ sales averages are a mean average based on a survey of analysts that cover Mettler-Toledo International.

Mettler-Toledo International (NYSE:MTD – Get Rating) last released its quarterly earnings results on Thursday, February 10th. The medical instruments supplier reported $10.53 EPS for the quarter, topping the consensus estimate of $10.07 by $0.46. The company had revenue of $1.04 billion for the quarter, compared to analyst estimates of $1.02 billion. Mettler-Toledo International had a return on equity of 438.50% and a net margin of 20.68%. The firm’s revenue was up 10.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $9.26 earnings per share.

A number of research firms recently weighed in on MTD. Wells Fargo & Company upgraded Mettler-Toledo International from an “equal weight” rating to an “overweight” rating and decreased their price target for the company from $1,600.00 to $1,410.00 in a research note on Monday, April 25th. StockNews.com assumed coverage on Mettler-Toledo International in a research report on Thursday, March 31st. They issued a “buy” rating on the stock. The Goldman Sachs Group lowered Mettler-Toledo International from a “neutral” rating to a “sell” rating and set a $1,240.00 target price for the company. in a research note on Thursday, March 10th. Finally, Robert W. Baird upped their target price on Mettler-Toledo International from $1,531.00 to $1,595.00 in a research note on Friday, February 11th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $1,449.25.

Mettler-Toledo International stock opened at $1,277.53 on Monday. The company has a debt-to-equity ratio of 9.22, a current ratio of 1.11 and a quick ratio of 0.75. Mettler-Toledo International has a 1-year low of $1,225.56 and a 1-year high of $1,714.75. The company has a market cap of $29.05 billion, a PE ratio of 38.93, a price-to-earnings-growth ratio of 1.77 and a beta of 1.08. The stock’s 50 day moving average price is $1,356.28 and its 200 day moving average price is $1,462.75.

In related news, insider Peter Aggersbjerg sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, March 4th. The shares were sold at an average price of $1,386.53, for a total value of $1,386,530.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Shawn Vadala sold 1,846 shares of the company’s stock in a transaction that occurred on Friday, February 25th. The shares were sold at an average price of $1,445.00, for a total transaction of $2,667,470.00. The disclosure for this sale can be found here. In the last 90 days, insiders sold 17,540 shares of company stock valued at $24,552,512. 2.80% of the stock is owned by insiders.

Several institutional investors and hedge funds have recently made changes to their positions in MTD. CVA Family Office LLC acquired a new position in Mettler-Toledo International in the 4th quarter valued at $25,000. Rockbridge Investment Management LCC bought a new stake in Mettler-Toledo International in the 4th quarter valued at $25,000. Eagle Bay Advisors LLC boosted its holdings in Mettler-Toledo International by 44.4% in the 3rd quarter. Eagle Bay Advisors LLC now owns 26 shares of the medical instruments supplier’s stock valued at $36,000 after purchasing an additional 8 shares during the period. Amplius Wealth Advisors LLC bought a new position in shares of Mettler-Toledo International during the 4th quarter worth about $39,000. Finally, Moors & Cabot Inc. bought a new position in shares of Mettler-Toledo International during the 3rd quarter worth about $51,000. Institutional investors own 92.56% of the company’s stock.

About Mettler-Toledo International (Get Rating)

Mettler-Toledo International Inc engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Featured Stories